June 26, 2020 at 6:30 PM CT
COVID-19 Date and Billing Guidance
Our Summary of COVID-19 Dates by Program has been updated with the latest information about the temporary measures UnitedHealthcare has enacted during the national public health emergency. When it’s time to submit a COVID-19 claim, check our COVID-19 Testing and Treatment Billing Guide for coding and other guidance.
COVID-19 Updates and Resources
Thank you for your dedication to the patients you serve. Please continue to visit our COVID-19 site for the latest news and information from UnitedHealthcare.
Claims and Payments
Eligibility and Benefits
Policies and Protocols
Prior Authorization and Notification
Latest UnitedHealthcare Provider News
-
UnitedHealthcare COVID-19 Provider Billing Guidance as of July 8, 2020
-
Provider Administered Drugs – Site of Care: Ocrevus® (Ocrelizumab)
Last Modified | 07.08.2020
Ocrevus® (ocrelizumab) is subject to site of care requirements. View the UnitedHealthcare article for details on correction of the policy titled Provider Administered Drugs – Site of Care.
Read Full Article -
Summary of COVID-19 Dates by Program
Last Modified | 07.01.2020
This document is intended to be a quick reference guide for the beginning and end dates of program, process or procedure changes that UnitedHealthcare has implemented as a result of COVID-19.
Read Full Article -
July 2020 UnitedHealthcare Network Bulletin
Last Modified | 07.01.2020
In the July Network Bulletin, you can learn about policy, protocol and program delays, code revisions for prior authorization and some site of service reviews, protocol and preferred drug list updates.
Read Full Article -
07/01/2020 – UnitedHealthcare Commercial Medical Policy Update Bulletin: July 2020
Last Modified | 07.01.2020
This bulletin provides complete details on recently approved, revised, and/or retired UnitedHealthcare Commercial Medical Policies, Medical Benefit Drug Policies, Coverage Determination Guidelines (CDG), and/or Utilization Review Guidelines (URG).
Read Full Article
UnitedHealthcare COVID-19 Provider Billing Guidance as of July 8, 2020
Last Modified | 07.08.2020
COVID-19 Testing and Testing-Related Services
Read Full ArticleProvider Administered Drugs – Site of Care: Ocrevus® (Ocrelizumab)
Last Modified | 07.08.2020
Ocrevus® (ocrelizumab) is subject to site of care requirements. View the UnitedHealthcare article for details on correction of the policy titled Provider Administered Drugs – Site of Care.
Read Full ArticleSummary of COVID-19 Dates by Program
Last Modified | 07.01.2020
This document is intended to be a quick reference guide for the beginning and end dates of program, process or procedure changes that UnitedHealthcare has implemented as a result of COVID-19.
Read Full ArticleJuly 2020 UnitedHealthcare Network Bulletin
Last Modified | 07.01.2020
In the July Network Bulletin, you can learn about policy, protocol and program delays, code revisions for prior authorization and some site of service reviews, protocol and preferred drug list updates.
Read Full Article07/01/2020 – UnitedHealthcare Commercial Medical Policy Update Bulletin: July 2020
Last Modified | 07.01.2020
This bulletin provides complete details on recently approved, revised, and/or retired UnitedHealthcare Commercial Medical Policies, Medical Benefit Drug Policies, Coverage Determination Guidelines (CDG), and/or Utilization Review Guidelines (URG).
Read Full Article
Explore the Network Bulletin for monthly updates on protocol and policy changes, administrative information, and more.
Visit the Network Bulletin Home Page